 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Incyte Genomics, Inc.
 |
Incyte Genomics, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Incyte posts narrower-than-expected Q2 loss Jul 19 2001 01:30 PM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
Gene Schemes
Jul 16 2001 12:00 AM PDT
The Gene Hackers
Jan 08 2001 12:00 AM PST
Nyuk Nyuk Nyuk: Investors Bop Biotech; Nasdaq Plunges
Mar 15 2000 12:00 AM PST
PROFILE |
 |
Incyte Genomics incites war against disease with its databases of information on human, animal, plant, and microorganism genes. The company sells subscriptions to its databases to leading pharmaceutical and biotechnology firms. Its LifeSeq database links biological data with genetic information to aid drug discovery. Incyte produces databases of full-length genes, gene mapping, microbial gene sequences, and animal genes. The company also provides microarray-based gene expression services, as well as DNA clone services and DNA screening. Incyte Genomics is expanding its proteomics services, which identify proteins related to diseases.
COMPETITION |
 |
Celera Genomics Group (CRA)
Gene Logic Inc. (GLGC)
Human Genome Sciences, Inc. (HGSI)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 194.20
1-Yr. Sales Growth: 23.7%
Employees: 1,322
Revenue per employee: $146,898.64
KEY PEOPLE |
 |
Roy A. Whitfield
CEO
John M. Vuko
CFO
CONTACT INFO |
 |
3160 Porter Dr.
Palo Alto, CA 94304
US
Phone: 650-855-0555
Fax: 650-855-0572
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |